Saturday, February 29, 2020 2:23:53 AM
Fellow Investors,
No doubt you’ve all been watching this week as markets have been shaken by announcements from numerous health organisations around the world, including perhaps THIS one from the WHO. Perhaps you’ve even noticed how relatively stable shares in NSCI have been. I’d like to explain briefly why I believe the market has not devalued NSCI to the same degree as the broader market.
While this latest threatening virus is a variant from the SARS virus years back, they are both strains in the Coronavirus ‘family’. In the wake of the SARS outbreak, researchers have used high-field NMR instruments to conduct the RESEARCH that has led to many of the cutting edge developments in virus prevention and suppression that will no doubt be built on as this current crisis progresses and well long after.
I would remind you all that Nanalysis DOES NOT claim to have solved the Coronavirus outbreak and we DO NOT expect to contribute to the global response to the present outbreak. What we do believe is that, over the LONG-TERM, high field NMR as well as our compact NMR devices will be a part of solving these major microbial problems, such as these dangerous strains of Coronavirus.
We are working to provide healthcare solutions with compact NMR aimed at the consumer-/patient-level detection solution while the high-field machines will continue to be used in the complex research that struggles to find solutions to these complex problems. This will be made possible by integrating data analytics and remote cloud access that will keep pace with and provide data to solutions development in real time, which as you all you all know, is part of our short-term strategy (see our LKA SUMMARY BRIEF).
So while we hope and pray for the health and safety of our family, friends, and colleagues around the world, please know that your friends at Nanalysis are hoping to one day contribute in some small way to the solution.
As always, if you have any question or feedback, please don’t hesitate to contact me directly at any method in my signature below.
Please contact me with any questions, feedback, or inquiries via phone or email using the contact details below and thank you for showing such support during this market upheaval.
Best regards,
Matt Sellers
Investor Relations Manager
http://www.nanalysis.com
P | 587.436.1291
F | 403.775.6683
LinkedIn Profile
Recent NSCI News
- Nanalysis Announces Second Quarter 2024 Results • PR Newswire (Canada) • 08/28/2024 08:14:00 PM
- Nanalysis Announces Second Quarter 2024 Conference Call • PR Newswire (Canada) • 08/14/2024 12:30:00 PM
- Nanalysis Announces New Director and Results of AGM • PR Newswire (Canada) • 06/28/2024 08:05:00 PM
- Nanalysis Announces Grant of Stock Options • PR Newswire (Canada) • 06/07/2024 03:40:00 PM
- Nanalysis Announces First Quarter 2024 Results • PR Newswire (Canada) • 05/29/2024 08:05:00 PM
- Nanalysis Announces First Quarter 2024 Conference Call • PR Newswire (Canada) • 05/21/2024 12:30:00 PM
- Nanalysis Announces Fourth Quarter and Full Year 2023 Results • PR Newswire (Canada) • 04/29/2024 08:05:00 PM
- /C O R R E C T I O N -- Nanalysis Scientific Corp./ • PR Newswire (Canada) • 04/24/2024 12:30:00 PM
- Nanalysis Announces Full Year 2023 Conference Call • PR Newswire (Canada) • 04/11/2024 12:30:00 PM
- Nanalysis Scientific Corp. Announces Director Resignation • PR Newswire (Canada) • 04/10/2024 01:55:00 PM
- AI Revolutionizes Drug Detection with Compact NMR and Machine Learning • AllPennyStocks.com • 04/04/2024 02:30:00 PM
- Nanalysis Corp. Receives Funding Supporting AI Software Development for Detection of Illicit Substances • PR Newswire (Canada) • 04/04/2024 12:30:00 PM
- NANALYSIS ANNOUNCES CLOSING OF PREVIOUSLY ANNOUNCED BEST EFFORTS PROSPECTUS EXEMPT OFFERING PURSUANT TO THE LISTED ISSUER EXEMPTION AND CONCURRENT PRIVATE PLACEMENT • PR Newswire (Canada) • 03/20/2024 01:32:00 PM
- L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - NSCI • PR Newswire (Canada) • 03/06/2024 09:17:00 PM
- Canadian Investment Regulatory Organization Trade Resumption - NSCI • PR Newswire (Canada) • 03/06/2024 09:15:00 PM
- Suspension de la négociation par l'Organisme canadien de réglementation des investissements - NSCI • PR Newswire (Canada) • 03/06/2024 09:10:00 PM
- Canadian Investment Regulatory Organization Trading Halt - NSCI • PR Newswire (Canada) • 03/06/2024 09:07:00 PM
- NANALYSIS ANNOUNCES UP TO $5.0 MILLION BEST EFFORTS PROSPECTUS EXEMPT OFFERING PURSUANT TO THE LISTED ISSUER EXEMPTION AND UP TO $1.0 MILLION CONCURRENT PRIVATE PLACEMENT • PR Newswire (Canada) • 03/06/2024 09:00:00 PM
- Nanalysis Announces Upcoming Webinar and Conference Participation • PR Newswire (Canada) • 02/07/2024 01:30:00 PM
- Nanalysis Achieves Record Revenue in Q4 • PR Newswire (Canada) • 02/06/2024 01:30:00 PM
- Nanalysis Scientific Corp. Provides Update on Security Services Business • PR Newswire (Canada) • 01/30/2024 01:30:00 PM
- Nanalysis Scientific Corp. Announces Grant of Restricted Share Units • PR Newswire (Canada) • 01/04/2024 12:11:00 AM
- Nanalysis Reports Third Quarter 2023 Results • PR Newswire (Canada) • 11/29/2023 10:19:00 PM
- Nanalysis Announces Third Quarter 2023 Conference Call • PR Newswire (Canada) • 11/15/2023 01:30:00 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM